USMLE Step 2 CK practice question: Giant cell arteritis with transient monocular vision loss: IV pulse glucocorticoids before biopsy

USMLE Step 2 CKMusculoskeletalInternal Medicine

A 76-year-old woman comes to the emergency department because of a 3-week history of a new right-sided headache, scalp tenderness when brushing her hair, and pain in her jaw while chewing. This morning, she had an episode of painless loss of vision in the right eye, which she describes as a curtain coming down; vision returned completely after 10 minutes. She also reports fatigue and a 3-kg (6.6-lb) weight loss. She has hypertension treated with losartan. Temperature is 37.6°C (99.7°F), pulse is 84/min, and blood pressure is 146/80 mm Hg. The right temporal artery is thickened, nodular, tender, and pulseless. Visual acuity is 20/25 in both eyes. Pupils are equal and reactive, without a relative afferent pupillary defect. Funduscopic examination shows no abnormalities. The remainder of the neurologic examination shows no abnormalities. Laboratory studies show: Hemoglobin 10.9 g/dL Platelet count 512,000/mm³ Erythrocyte sedimentation rate 96 mm/h C-reactive protein 8.4 mg/dL (N<0.8)

Which of the following is the most appropriate next step in management?

  1. Temporal artery biopsy before glucocorticoid therapy
  2. Oral prednisone 15 mg daily
  3. Intravenous methylprednisolone
  4. Carotid duplex ultrasonography and aspirin
  5. Tocilizumab without glucocorticoids
Show answer and explanation

Correct answer: C. Intravenous methylprednisolone

This patient has giant cell arteritis (GCA): age >50 years, a new localized headache, scalp tenderness, jaw claudication, an abnormal temporal artery, constitutional symptoms, markedly elevated ESR and CRP, anemia of inflammation, and reactive thrombocytosis. GCA is a granulomatous vasculitis of large and medium-sized arteries, particularly the extracranial branches of the carotid artery. Her transient monocular vision loss (amaurosis fugax) reflects ischemia in the ophthalmic artery territory — most often the posterior ciliary arteries supplying the optic nerve head (the substrate of arteritic anterior ischemic optic neuropathy). It is a warning sign: permanent, often bilateral, blindness can follow within days and rarely recovers.

Glucocorticoids must be started immediately on clinical suspicion and should never be delayed for a biopsy. The 2021 ACR/Vasculitis Foundation guideline recommends high-dose oral glucocorticoids (e.g., prednisone 1 mg/kg/day, up to 60 mg) for GCA without cranial ischemic complications, but IV pulse methylprednisolone (typically 500–1000 mg daily for 3 days) for patients with threatened or active vision loss, followed by high-dose oral prednisone. Temporal artery biopsy (unilateral, a segment >1 cm long) is preferred for diagnosis in the United States and remains informative if performed within about 2 weeks of starting glucocorticoids, because granulomatous inflammation resolves slowly. Tocilizumab (an IL-6 receptor antagonist) added to tapering glucocorticoids is recommended for newly diagnosed GCA to reduce relapses and cumulative glucocorticoid exposure.

High-yield summary: Suspected GCA → glucocorticoids first, biopsy within 2 weeks. Visual symptoms (amaurosis fugax, diplopia, vision loss) → IV pulse methylprednisolone; otherwise oral prednisone 40–60 mg/day. Add tocilizumab as a glucocorticoid-sparing agent.

Why the other options are wrong

  • A. Temporal artery biopsy before glucocorticoid therapy — Biopsy confirms the diagnosis but must not delay treatment; it remains informative for about 2 weeks after glucocorticoids are started, whereas untreated ocular ischemia can cause permanent blindness within hours to days.
  • B. Oral prednisone 15 mg daily — Prednisone 12.5–25 mg daily is the starting dose for isolated polymyalgia rheumatica; it is inadequate for GCA, particularly with visual symptoms.
  • D. Carotid duplex ultrasonography and aspirin — Amaurosis fugax in older adults can result from carotid atheroembolism, but jaw claudication, scalp tenderness, an abnormal temporal artery, and very high inflammatory markers point to GCA, which requires immediate glucocorticoids; aspirin alone does not treat vasculitis.
  • E. Tocilizumab without glucocorticoids — Tocilizumab is used together with glucocorticoids as a glucocorticoid-sparing agent; its onset is too slow to protect vision, and it is not used as initial monotherapy.

Key point

In suspected giant cell arteritis with visual symptoms, start IV pulse methylprednisolone immediately — before temporal artery biopsy, which should be performed within 2 weeks.

Memory hook

GCA with any eye symptom: steroids before scalpel — pulse IV methylprednisolone now; the biopsy stays positive for about 2 weeks.

Share: Telegram WhatsApp X LinkedIn

Practice like this every day

15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.

Play free

More free questions in this system

Supraspinatus tear: empty-can test and suprascapular nerveUSMLE Step 1 · MusculoskeletalAcute monoarthritis with suspected septic arthritis: arthrocentesis before antibioticsUSMLE Step 2 CK · MusculoskeletalInferior STEMI with right ventricular infarction and hypotensionUSMLE Step 2 CK · CardiovascularDiabetic ketoacidosis with hypokalemia: potassium before insulinUSMLE Step 2 CK · EndocrineEmpiric therapy for community-acquired bacterial meningitis in an adult older than 50 yearsUSMLE Step 2 CK · NervousHepatitis B immunoprophylaxis for a preterm infant of an HBsAg-positive motherUSMLE Step 2 CK · Pediatrics

All free questions →